| 10526358 |
Crystalline forms |
Mazen Hanna, Ning Shan, David R. Weyna |
2020-01-07 |
| 10519176 |
Crystalline forms |
Mazen Hanna, Ning Shan, David R. Weyna, Paul K. Isbester, Xufeng Sun |
2019-12-31 |
| 10323052 |
Crystallization method and bioavailability |
Mazen Hanna, Ning Shan, David R. Weyna, Raymond K. Houck |
2019-06-18 |
| 10093691 |
Crystallization method and bioavailability |
Mazen Hanna, Ning Shan, David R. Weyna, Raymond K. Houck |
2018-10-09 |
| 9682091 |
Oral forms of a phosphonic acid derivative |
Mazen Hanna, Ning Shan, David R. Weyna |
2017-06-20 |
| 9340565 |
Crystalline forms |
Mazen Hanna, Ning Shan, David R. Weyna, Paul K. Isbester, Xufeng Sun |
2016-05-17 |
| 9334296 |
Crystallization method and bioavailability |
Mazen Hanna, Ning Shan, David R. Weyna, Raymond K. Houck |
2016-05-10 |
| 9169279 |
Crystallization method and bioavailability |
Mazen Hanna, Ning Shan, David R. Weyna, Raymond K. Houck |
2015-10-27 |
| 9040535 |
Crystalline molecular comlpexes of tadalafil |
Mazen Hanna, Ning Shan, David R. Weyna |
2015-05-26 |
| 8980868 |
Oral forms of a phosphonic acid derivative |
Mazen Hanna, Ning Shan, David R. Weyna |
2015-03-17 |
| 8933057 |
Crystallization method and bioavailability |
Mazen Hanna, Ning Shan, David R. Weyna, Raymond K. Houck |
2015-01-13 |
| 8586587 |
Crystalline molecular complex of tadalafil and methylparaben |
Mazen Hanna, Ning Shan, David R. Weyna |
2013-11-19 |
| 8486927 |
Crystalline forms of lamotrigine |
Mazen Hanna, Ning Shan |
2013-07-16 |
| 8399023 |
Crystallization method and bioavailability |
Mazen Hanna, Ning Shan, David R. Weyna, Raymond K. Houck |
2013-03-19 |
| 8389512 |
In vivo studies of crystalline forms of meloxicam |
Mazen Hanna, Ning Shan, David R. Weyna |
2013-03-05 |
| 8124603 |
In vivo studies of crystalline forms of meloxicam |
Mazen Hanna, Ning Shan, David R. Weyna |
2012-02-28 |